| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.
Over the last 12 months, insiders at Estrella Immunopharma, Inc. have bought $0 and sold $0 worth of Estrella Immunopharma, Inc. stock.
On average, over the past 5 years, insiders at Estrella Immunopharma, Inc. have bought $44.68B and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 141,970 shares for transaction amount of $44.68B was made by Li Jianwei (Co‑Chief Executive Officer) on 2022‑03‑04.
| Increased Positions | 5 | +45.45% | 356,110 | +121.84% |
| Decreased Positions | 4 | -36.36% | 35,241 | -12.06% |
| New Positions | <1 | New | 91,599 | New |
| Sold Out Positions | <1 | Sold Out | 10,640 | Sold Out |
| Total Postitions | 12 | +9.09% | 613,145 | +109.78% |
| Geode Capital Management, Llc | $108.00 | 0.26% | 93,418 | +16,862 | +22.03% | 2024-12-31 |
| Ubs Group Ag | $76.00 | 0.18% | 65,167 | +58,644 | +899.03% | 2024-12-31 |
| Atw Spac Management Llc | $46.00 | 0.11% | 40,000 | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $29.00 | 0.07% | 24,653 | -465 | -1.85% | 2025-03-31 |
| State Street Corp | $26.00 | 0.06% | 22,352 | +22,352 | New | 2024-12-31 |
| Vanguard Group Inc | $25.00 | 0.06% | 21,684 | 0 | 0% | 2024-12-31 |
| Two Sigma Securities, Llc | $12.00 | 0.03% | 10,640 | +10,640 | New | 2024-12-31 |
| Maso Capital Partners Ltd | $12.00 | 0.03% | 10,000 | 0 | 0% | 2024-12-31 |
| Tower Research Capital Llc (Trc) | $4.00 | 0.01% | 3,788 | -1,940 | -33.87% | 2024-12-31 |
| Bank Of America Corp /De/ | $0 | 0% | 83 | 0 | 0% | 2024-12-31 |